Sp740
PANEL DISCUSSION
Date
May 20, 2024
Presenters
Cleveland Clinic Foundation
Boston Children's Hospital
Department of Pathology & Laboratory Medicine Rutgers New Jersey School of Medicine
Icahn School of Medicine at Mount Sinai
Tracks
Related Products
DUAL ACTIVATION OF GCGR/GLP1R SIGNALING AMELIORATES INTESTINAL FIBROSIS VIA METABOLIC REGULATION OF HISTONE H3K9 LACTYLATION IN EPITHELIAL CELLS
Intestinal fibrosis is a significant clinical challenge in inflammatory bowel diseases, but no effective anti-fibrotic therapy is currently available. GCGR and GLP1R are both peptide hormone receptors involved in energy metabolism of epithelial cells…
THE BREATH METABOLOME SIGNATURE IS LINKED WITH DIAGNOSIS OF EOSINOPHILIC ESOPHAGITIS:
PILOT STUDY ASSESSING EXHALED VOLATILE ORGANIC COMPOUNDS
Eosinophilic esophagitis (EoE) is a chronic immune mediated esophageal condition leading to dysphagia, strictures, and food impactions. Endoscopic biopsies remain the gold standard for diagnosis…
INTEGRIN INHIBITION REDUCES PROFIBROTIC RESPONSES IN CROHN’S DISEASE (CD) HUMAN INTESTINAL MYOFIBROBLASTS IN VITRO AND AMELIORATES EXPERIMENTAL INTESTINAL FIBROSIS IN VIVO - A POTENTIAL NOVEL APPROACH TO CD STRICTURE THERAPY
_INTRODUCTION:_ Despite effective anti-inflammatory therapies, ~70% of CD patients require surgery in their lifetime, due to fibrostenotic strictures linked to excess extracellular matrix (ECM) deposition…
